Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May 1;44(1):210.
doi: 10.1007/s10792-024-03152-3.

The effect of adjuvant Mitomycin C during vitrectomy on functional and anatomical outcomes in patients with severe diabetic tractional retinal detachment

Affiliations

The effect of adjuvant Mitomycin C during vitrectomy on functional and anatomical outcomes in patients with severe diabetic tractional retinal detachment

Ihsan Gokhan Gurelik et al. Int Ophthalmol. .

Abstract

Purpose: To evaluate the effect of adjuvant Mitomycin C (MMC) use on the anatomical and functional success of vitreoretinal surgery (VRS) in severe diabetic tractional retinal detachment (dTRD) patients.

Methods: A retrospective analysis of consecutive patients undergoing VRS due to severe dTRD was conducted. Patients were categorized into those who received 20 µg/0.1 mL MMC via MMC sandwich method (Group 1) and those who did not (Group 2). Demographics, surgical characteristics, visual outcomes, and complications that may related to MMC were analyzed.

Results: A total of 25 eyes were included, 13 in Group 1 and 12 in Group 2. No statistical difference was observed in baseline characteristics between the groups. The mean best-corrected visual acuity was 1.90 ± 0.43 logMAR and 1.93 ± 0.41 logMAR preoperatively and 1.60 ± 0.78 logMAR and 1.56 ± 0.78 logMAR postoperatively in Groups 1 and 2, respectively (p = 0.154). The postoperative mean intraocular pressure was 16.23 ± 2.55 mmHg and 13.08 ± 4.94 mmHg in Groups 1 and 2, respectively (p = 0.225). The rate of re-surgery was significantly lower in Group 1 (0% vs. 41.7% in Group 2, p = 0.015). Retina was attached in all patients at the last visit. No MMC-related complication was recorded.

Conclusion: Intraoperative adjuvant MMC application for severe dTRD significantly reduces re-surgery rates with good anatomical and functional outcomes safely.

Keywords: Fibrovascular proliferation; Mitomycin C; Proliferative diabetic retinopathy; Vitrectomy.

PubMed Disclaimer

Similar articles

Cited by

References

    1. The Diabetic Retinopathy Vitrectomy Study Research Group (1988) Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision; clinical application of results of a randomized trial:diabetic retinopathy vitrectomy study report 4. Ophthalmology 95(10):1321–1334. https://doi.org/10.1016/s0161-6420(88)33014-9 - DOI
    1. La Heij EC, Tecim S, Kessels AG, Liem AT, Japing WJ, Hendrikse F (2004) Clinical variables and their relation to visual outcome after vitrectomy in eyes with diabetic retinal traction detachment. Graefes Arch Clin Exp Ophthalmol 242:210–217 - DOI - PubMed
    1. Meleth AD, Carvounis PE (2014) Outcomes of vitrectomy for tractional retinal detachment in diabetic retinopathy. Int Ophthalmol Clin 54(2):127–139 - DOI - PubMed
    1. McCullough P, Mohite A, Virgili G, Lois N (2023) Outcomes and complications of pars plana vitrectomy for tractional retinal detachment in people with diabetes: a systematic review and meta-analysis. JAMA Ophthalmol 141(2):186–195. https://doi.org/10.1001/jamaophthalmol.2022.5817 - DOI - PubMed - PMC
    1. Al-Khersan H, Venincasa MJ, Kloosterboer A, Sridhar J, Smiddy WE, Townsend JH et al (2020) Pars plana vitrectomy reoperations for complications of proliferative diabetic retinopathy. Clin Ophthalmol (Auckland, NZ) 14:1559–1563. https://doi.org/10.2147/opth.s252285 - DOI

MeSH terms

LinkOut - more resources